Biodistribution and bioactivity of tetra-pegylated meta-tetra(hydroxyphenyl)chlorin compared to native meta-tetra(hydroxyphenyl)chlorin in a rat liver tumor model
Jp. Rovers et al., Biodistribution and bioactivity of tetra-pegylated meta-tetra(hydroxyphenyl)chlorin compared to native meta-tetra(hydroxyphenyl)chlorin in a rat liver tumor model, PHOTOCHEM P, 71(2), 2000, pp. 211-217
It has been proposed that the construction of a photosensitizer-polymer con
jugate would lead to an increased selective retention of the drug in tumor
tissue resulting in an enhancement of selective turner destruction by light
in photodynamic therapy. In this study the kinetics of a tetrapegylated de
rivative of meta-tetra(hydroxyphenyl)chlorin (mTHPC-PEG) were compared with
those of native meta-tetra(hydroxyphenyl)chlorin (mTHPC) in a rat liver tu
mor model. In addition, the time course of bioactivity of both drugs was st
udied in normal liver tissue. Pegylation of mTHPC resulted in a two-fold in
crease in the plasma half-life time, a five-fold decrease in Liver uptake a
nd an increase in the tumor selectivity at early time intervals after drug
administration, However, although mTHPC concentrations in liver decrease ra
pidly with time, mTHPC-PEG liver concentrations increased as a function of
time. This led to a loss of tumor selectivity at all but the earliest time
points, whereas with mTHPC tumor selectivity increased with time. For both
drugs the time course of bioactivity in the liver parallels drug concentrat
ion levels with extensive necrosis after irradiation of mTHPC-PEG-sensitize
d liver tissue up to drug-light intervals of 120 h, It is concluded that on
balance mTHPC-PEG does not appear to show any benefits over native mTHPC f
or the treatment of liver tumors, as normal liver tissue accumulates the co
mpound. However, pegylation is a potentially promising strategy,vith an inc
rease in tumor selectivity and reduced liver uptake if accumulation in the
liver can be prevented.